. . . . . . . . . . . . "p(HGNC:CCL2) -> path(SDIS:metastasis)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The potential contribution of CCL2 to breast cancer progression was further supported by a study demonstrating that the ability of CCL2-expressing human breast carcinoma MDA-231 cells to form lung micrometastases in mice was significantly inhibited by neutralizing antibodies to CCL2 [21]." . . "Selventa" . . . . "2014-07-03T14:30:09.735+02:00"^^ . . .